Right ventricular function and iron deficiency in acute heart failure.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
25 May 2021
Historique:
received: 03 06 2020
revised: 03 08 2020
accepted: 24 09 2020
pubmed: 24 2 2021
medline: 25 11 2021
entrez: 23 2 2021
Statut: ppublish

Résumé

Iron deficiency (ID) is a frequent finding in patients with chronic and acute heart failure (AHF) along the full spectrum of left ventricular ejection fraction (LVEF). Iron deficiency has been related to ventricular systolic dysfunction, but its role in right ventricular function has not been evaluated. We sought to evaluate whether ID identifies patients with greater right ventricular dysfunction in the setting of AHF. We prospectively included 903 patients admitted with AHF. Right systolic function was evaluated by tricuspid annular plane systolic excursion (TAPSE) and the ratio TAPSE/pulmonary artery systolic pressure (TAPSE/PASP). Iron deficiency was defined, according to European Society of Cardiology criteria, as serum ferritin <100 mg/dL (absolute ID) or ferritin 100-299 mg/dL and transferrin saturation (TSAT) <20% (functional ID). The relationships among the exposures with right ventricular systolic function were evaluated by multivariate linear regression analyses. The mean age of the sample was 74.3 ± 10.6 years, 441 (48.8%) were female, 471 (52.2%) exhibited heart failure with preserved ejection fraction, and 677 (75.0%) showed ID. The mean LVEF, TAPSE, and TAPSE/PASP were 49 ± 15%, 18.6 ± 3.9 mm, and 0.45 ± 0.18, respectively. The median (interquartile range) amino-terminal pro-brain natriuretic peptide was 4015 (1807-8775) pg/mL. In a multivariable setting, lower TSAT and ferritin were independently associated with lower TAPSE (P < 0.05 for both comparisons). Transferrin saturation (P = 0.017), and not ferritin (P = 0.633), was independently associated with TAPSE/PASP. In AHF, proxies of ID were associated with right ventricular dysfunction. Further studies should confirm these findings and evaluate the pathophysiological facts behind this association.

Identifiants

pubmed: 33620455
pii: 5974999
doi: 10.1093/ehjacc/zuaa028
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

406-414

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Auteurs

Gema Miñana (G)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
CIBER Cardiovascular, Madrid, Spain.

Enrique Santas (E)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.

Rafael de la Espriella (R)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.

Eduardo Núñez (E)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.

Miguel Lorenzo (M)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.

Gonzalo Núñez (G)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.

Ernesto Valero (E)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
CIBER Cardiovascular, Madrid, Spain.

Vicent Bodí (V)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
CIBER Cardiovascular, Madrid, Spain.

Francisco J Chorro (FJ)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
CIBER Cardiovascular, Madrid, Spain.

Juan Sanchis (J)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
CIBER Cardiovascular, Madrid, Spain.

Alain Cohen-Solal (A)

Cardiology Department, UMR-S942, University of Paris, Lariboisiere Hospital, AP-HP, 2 rue ambroise pare, Paris 75010, France.

Antoni Bayés-Genís (A)

CIBER Cardiovascular, Madrid, Spain.
Cardiology Department and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Autonomous University of Barcelona, Barcelona, Spain.

Julio Núñez (J)

Cardiology Department, Hospital Clínico Universitario, Universitat de Valencia, INCLIVA, Avda. Blasco Ibáñez 17, 46010 Valencia, Spain.
CIBER Cardiovascular, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH